SPY304.32+1.35 0.45%
DIA254.29-0.06 -0.02%
IXIC9,489.87+120.88 1.29%

Aclaris Therapeutics Q1 EPS $(0.370) Up From $(0.910) YoY, Sales $1.407M Up From $1.263M YoY

Aclaris Therapeutics (NASDAQ:ACRS) reported quarterly losses of $(0.370) per share. This is a 59.34 percent increase over losses of $(0.910) per share from the same period last year. The company reported $1.407 million

Benzinga · 05/07/2020 20:19

Aclaris Therapeutics (NASDAQ:ACRS) reported quarterly losses of $(0.370) per share. This is a 59.34 percent increase over losses of $(0.910) per share from the same period last year. The company reported $1.407 million in sales this quarter. This is a 11.40 percent increase over sales of $1.263 million the same period last year.